JP2003146873A - Iron absorption promoter - Google Patents

Iron absorption promoter

Info

Publication number
JP2003146873A
JP2003146873A JP2001343851A JP2001343851A JP2003146873A JP 2003146873 A JP2003146873 A JP 2003146873A JP 2001343851 A JP2001343851 A JP 2001343851A JP 2001343851 A JP2001343851 A JP 2001343851A JP 2003146873 A JP2003146873 A JP 2003146873A
Authority
JP
Japan
Prior art keywords
vinegar
iron
iron absorption
absorption
absorption promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001343851A
Other languages
Japanese (ja)
Inventor
Kazuo Kaminakai
和男 上中居
Yumi Shimoji
由美 下地
Mino Sueda
美濃 末田
Satoshi Ujiie
聡 氏家
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tamanoi Vinegar Co Ltd
Original Assignee
Tamanoi Vinegar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tamanoi Vinegar Co Ltd filed Critical Tamanoi Vinegar Co Ltd
Priority to JP2001343851A priority Critical patent/JP2003146873A/en
Publication of JP2003146873A publication Critical patent/JP2003146873A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an iron absorption promoter that includes vinegar so that the absorption of iron into blood may be increased. SOLUTION: The iron absorption promoter includes vinegar. The vinegars is at least one selected from the group consisting of fruit vinegar, black vinegar, rice vinegar, alcohol vinegar and cereal vinegars. The acidity of the vinegar is 0.3-1.3 w/v%. In another embodiment, this iron absorption promoter may includes prune vinegar of 0.3-1.3 w/v% acidity.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本願発明は、鉄の吸収を促進
し、鉄不足状態を改善する鉄吸収促進剤に関するもので
ある。
TECHNICAL FIELD The present invention relates to an iron absorption promoter that promotes iron absorption and improves iron deficiency.

【0002】[0002]

【従来の技術】鉄は、生命を維持する上で不可欠である
必須微量栄養素の一つであって、酸素を運搬する赤血球
中のヘモグロビンの主要成分であると共に、筋肉中のミ
オグロビン及び体内の酸化還元に関与する酵素の成分と
して重要であり、生体内における増血作用に欠かせない
因子である。
2. Description of the Related Art Iron is one of the essential micronutrients essential for sustaining life and is a major component of hemoglobin in red blood cells that carry oxygen, as well as myoglobin in muscle and oxidation in the body. It is an important component of the enzyme involved in the reduction and is an essential factor for the blood increasing action in the living body.

【0003】鉄の欠乏は、出血、尿管内出血、妊娠、鉄
欠乏食の摂取、腸からの鉄吸収異常等によって生じ、こ
れが持続すると、鉄欠乏性貧血症に至る。
Iron deficiency is caused by bleeding, ureteral bleeding, pregnancy, intake of iron-deficient diet, abnormal absorption of iron from the intestine, and the like, which persists leading to iron deficiency anemia.

【0004】従来、鉄の欠乏に際しては、クエン酸鉄、
乳酸鉄、塩化第二鉄、硫酸鉄などの非ヘム鉄及び肉、レ
バー等に含まれるヘム鉄を摂取することやビタミンC、
システインなど鉄の吸収を促進させる成分の多い食品を
摂取することが勧められ、鉄の吸収を低下させるフィチ
ン酸、リン酸、タンニン酸などを多く含む食品の摂取を
避けることが望ましいとされている。
Conventionally, when deficiency of iron, iron citrate,
Ingestion of non-heme iron such as iron lactate, ferric chloride and iron sulfate and heme iron contained in meat, liver, etc., vitamin C,
It is recommended to eat foods that contain many components that promote iron absorption, such as cysteine, and it is desirable to avoid foods that contain a large amount of phytic acid, phosphoric acid, tannic acid, etc. that decrease iron absorption. .

【0005】食酢は、古くから調味料として広く使用さ
れているが、調味のみならず、抗菌等の他の機能も利用
されてきた。特に、経験的に酢を摂ると健康によいとい
うことが知られており、民間薬的な効用を期待した使わ
れ方もされている。
Although vinegar has been widely used as a seasoning for a long time, not only seasoning but also other functions such as antibacterial have been utilized. In particular, it is empirically known that taking vinegar is good for health, and it is also used with the expectation that it will be used as a folk medicine.

【0006】食酢には、胃液の分泌促進、疲労回復、脂
肪肝防御、高血圧の予防、過酸化脂質の低下、コレステ
ロールの低下、血中アルコールの低減等の効果があると
されている。
Vinegar is said to be effective in promoting secretion of gastric juice, recovery from fatigue, protection of fatty liver, prevention of high blood pressure, reduction of lipid peroxide, reduction of cholesterol, reduction of blood alcohol.

【0007】[0007]

【発明が解決しようとする課題】鉄は、血中に吸収され
にくい微量元素とされ、腸管から吸収される鉄は10%
程度であることが知られている。それ故、鉄を大量に経
口摂取しても、摂取した鉄の大部分はそのまま体外に排
出されてしまうため、腸管からの鉄の吸収が促進される
素材が望まれている。
Iron is a trace element that is difficult to be absorbed in blood, and iron absorbed from the intestinal tract is 10%.
It is known to be degree. Therefore, even if a large amount of iron is orally ingested, most of the ingested iron is excreted out of the body as it is, and thus a material that promotes absorption of iron from the intestinal tract is desired.

【0008】しかし、食酢が鉄の吸収を促進することに
ついては、未だ具体的にされていない。
However, vinegar has not yet been specifically defined as promoting the absorption of iron.

【0009】本願発明は、血中に吸収されにくい鉄の吸
収率を向上させる、食酢を含有してなる鉄吸収促進剤を
提供するものである。
The present invention provides an iron absorption enhancer containing vinegar which improves the absorption rate of iron which is difficult to be absorbed in blood.

【0010】[0010]

【課題を解決するための手段】本願発明者は、上述の課
題に対して鋭意検討を重ねた結果、食酢と鉄分を同時に
摂取することによって鉄の吸収が促進されることを見い
出し、本願発明を完成するに至った。
Means for Solving the Problems The inventors of the present invention have made extensive studies on the above problems, and as a result, found that the ingestion of iron is promoted by ingesting vinegar and iron at the same time. It came to completion.

【0011】即ち、本願発明の鉄吸収促進剤は、食酢を
含有してなることを特徴とする鉄吸収促進剤である。こ
の発明の好適形態においては、上記食酢は、果実酢、黒
酢、米酢、アルコール酢、穀物酢のうちいずれか一種以
上からなり、上記食酢を、酢酸換算の酸度として、0.
3w/v%以上1.3w/v%以下含有してなる。ま
た、プルーン酢を、酢酸換算の酸度として、0.3w/
v%以上1.3w/v%以下含有してなる。
That is, the iron absorption promoter of the present invention is an iron absorption promoter containing vinegar. In a preferred embodiment of the present invention, the vinegar comprises at least one of fruit vinegar, black vinegar, rice vinegar, alcohol vinegar, and grain vinegar, and the vinegar has an acetic acid equivalent acidity of 0.
The content is 3 w / v% or more and 1.3 w / v% or less. In addition, prune vinegar has an acidity of acetic acid equivalent of 0.3 w /
The content is v% or more and 1.3 w / v% or less.

【0012】[0012]

【発明の実施の形態】本願発明の鉄吸収促進剤は、食酢
を含有してなる鉄吸収促進剤である。
BEST MODE FOR CARRYING OUT THE INVENTION The iron absorption promoter of the present invention is an iron absorption promoter containing vinegar.

【0013】本願発明において、食酢は、醸造酢と合成
酢のいずれであってもよい。ここで、醸造酢は含アルコ
ールもろみが酢酸菌の酸化発酵により食酢となるもの
で、原料により多種類のものがあり、具体的には、果実
酢(プルーン酢、ブルーベリー酢、リンゴ酢、ブドウ
酢、柿酢、桃酢、ストロベリー酢等)、黒酢(玄米酢、
玄麦酢等)、米酢(純米酢等)、酒精酢(アルコール酢
等)、穀物酢(麦芽酢、粕酢、コーン酢、小麦酢、鳩麦
酢、ライ麦酢、小麦胚芽酢、そば酢、アマランサス酢
等)、穀物酢及び果実酢以外の醸造酢(タマネギ酢、ト
マト酢、梅酢、しそ酢、ハーブ酢、海藻酢等)が挙げら
れる。合成酢は、氷酢酸又は酢酸の希釈液に醸造酢を4
0%以上配合したものである。
In the present invention, the vinegar may be brewed vinegar or synthetic vinegar. Here, in brewed vinegar, alcohol-containing mash becomes edible vinegar by oxidative fermentation of acetic acid bacteria, and there are various types of raw materials. Specifically, fruit vinegar (prune vinegar, blueberry vinegar, apple vinegar, grape vinegar) , Persimmon vinegar, peach vinegar, strawberry vinegar, etc.), black vinegar (brown rice vinegar,
Vinegar vinegar, etc.), rice vinegar (pure rice vinegar, etc.), sake vinegar (alcohol vinegar, etc.), grain vinegar (malt vinegar, lees vinegar, corn vinegar, wheat vinegar, pigeon vinegar, rye vinegar, wheat germ vinegar, buckwheat vinegar, Amaranth vinegar, etc.), and brewed vinegar other than grain vinegar and fruit vinegar (onion vinegar, tomato vinegar, plum vinegar, shiso vinegar, herb vinegar, seaweed vinegar, etc.). Synthetic vinegar uses 4 parts of brewed vinegar in glacial acetic acid or dilute acetic acid.
It is a mixture of 0% or more.

【0014】本願発明では、鉄の吸収促進という効果の
点から、食酢は、果実酢、黒酢、米酢、アルコール酢、
穀物酢のうちいずれか一種以上からなるのが好ましく、
食酢を、酢酸換算の酸度として、0.3w/v%以上
1.3w/v%以下含有してなるのが好ましい。
In the present invention, from the viewpoint of promoting the absorption of iron, vinegar includes fruit vinegar, black vinegar, rice vinegar, alcohol vinegar,
It is preferably composed of one or more of grain vinegar,
The vinegar preferably contains 0.3 w / v% or more and 1.3 w / v% or less in terms of acidity in terms of acetic acid.

【0015】本願発明にいう黒酢は、広く一般に黒酢と
呼ばれるものはすべて含まれ、天然壺酢製法によるもの
に限定されない。
The black vinegar referred to in the present invention includes all that are generally called black vinegar, and is not limited to the natural vinegar production method.

【0016】本願発明において、プルーン酢は、プルー
ン果汁を原料として作られたものである。プルーン酢を
含有してなる場合には、プルーン酢を、酢酸換算の酸度
として0.3w/v%以上1.3w/v%以下含有して
なるのが好ましい。
In the present invention, prune vinegar is made from prune juice. In the case of containing prune vinegar, it is preferable that the prune vinegar is contained in an acidity of 0.3 w / v% or more and 1.3 w / v% or less in terms of acetic acid.

【0017】本願発明の鉄吸収促進剤は、適宜、ビタミ
ンCその他の鉄吸収代謝促進剤、鉄化合物などを混合し
てなるものであり、本願発明の効果を妨げない範囲で、
例えば、栄養剤、微量元素などの各種物質を混合するこ
ともできる。
The iron absorption promoter of the present invention is a mixture of vitamin C and other iron absorption and metabolism promoters, iron compounds, etc., as long as the effects of the present invention are not impaired.
For example, various substances such as nutrients and trace elements can be mixed.

【0018】本願発明の鉄吸収促進剤は、そのまま用い
るだけでなく、凍結乾燥や噴霧乾燥等により乾燥した
り、必要成分を精製したりして用いることも可能であ
る。
The iron absorption promoter of the present invention can be used not only as it is, but also by being dried by freeze-drying or spray-drying, or by purifying necessary components.

【0019】本願発明の鉄吸収促進剤は、医薬品、医薬
部外品、鉄吸収促進効果を有する飲食物や食品などの形
態で提供することができる。
The iron absorption enhancer of the present invention can be provided in the form of medicines, quasi drugs, foods and drinks having an iron absorption promoting effect, and foods.

【0020】医薬品とする場合には、例えば、適宜製剤
上の賦形剤、結合剤、崩壊剤、滑沢剤、希釈剤、矯味剤
等の製剤技術の分野において通常使用しうる既知の補助
剤を混合し、経口的又は非経口的に投与される液剤、錠
剤、散剤、顆粒剤、糖衣錠、カプセル、腸溶剤、坐剤、
軟膏剤、吸入剤、シロップ剤、トローチ剤、注射剤など
の任意の剤型とする。
In the case of a pharmaceutical product, for example, an excipient, binder, disintegrating agent, lubricant, diluent, flavoring agent or the like known in the field of formulation technology, which are commonly used in the formulation, are appropriately used. , Orally or parenterally administered as a liquid, tablet, powder, granule, dragee, capsule, enteric agent, suppository,
It may be in any dosage form such as an ointment, an inhalant, a syrup, a troche, and an injection.

【0021】医薬部外品とする場合には、例えば、日常
的に容易に摂取することができ、生体に対し十分な鉄吸
収効果をもたらす、飲料、タブレット、カプセル、トロ
ーチ(飴)、顆粒などにする。
In the case of quasi-drugs, for example, beverages, tablets, capsules, troches (candy), granules, etc. that can be easily ingested on a daily basis and have a sufficient iron absorption effect on the living body. To

【0022】鉄吸収促進効果を有する飲食物とする場合
には、例えば、食品素材(果実やゼリーなども含む)、
乳成分、炭酸、賦形剤(造粒剤含む)、希釈剤、更に、
甘味料、フレーバー、小麦粉、でんぷん、糖、油脂類等
の各種タンパク質、糖質原料、ビタミン、ミネラルなど
から選ばれた一種又は二種以上を混合し、缶飲料、ボト
ル飲料、固形食物等、スポーツ飲料、果実飲料、乳飲
料、乳性飲料、ゼリー、ゼリー飲料、炭酸飲料などの飲
食物にする。
When the food or drink has an iron absorption promoting effect, for example, food materials (including fruits and jellies),
Milk components, carbonic acid, excipients (including granulating agents), diluents,
Mixing one or more selected from various proteins such as sweeteners, flavors, flour, starch, sugar, fats and oils, sugar raw materials, vitamins, minerals, canned beverages, bottled beverages, solid foods, sports, etc. Beverages, fruit drinks, milk drinks, dairy drinks, jellies, jelly drinks, carbonated drinks and other food and drink.

【0023】鉄吸収促進効果を有する食品とする場合に
は、例えば、糖類、脂肪等に、微量元素、ビタミン類、
乳化剤、香料などと共に配合し、自然流動食、半消化態
栄養食、成分栄養食とするか、固形、液状の食品、調味
料、嗜好品、農産食品、発酵食品、畜農食品、水産食品
等にする。
In the case of a food having an effect of promoting iron absorption, for example, sugars, fats, trace elements, vitamins,
Blended with emulsifiers, flavors, etc. to make natural liquid food, semi-digestible nutrition food, ingredient nutrition food, solid, liquid food, seasoning, luxury food, agricultural food, fermented food, livestock food, seafood, etc. To

【0024】[0024]

【実施例】(実施例1) 鉄欠乏ラットにおける鉄吸収促進効果 鉄を摂取したときの血中への鉄分の吸収率は、体内の鉄
の充足状態により左右され、鉄欠乏状態では吸収が促進
されるようになっている。そこで鉄欠乏状態にしたラッ
トを用いて、鉄の吸収と酢による促進があるかどうかを
調べた。
[Examples] (Example 1) Iron absorption-promoting effect in iron-deficient rats The absorption rate of iron into blood when iron is ingested is dependent on the state of iron sufficiency in the body, and absorption is promoted in the iron-deficient state. It is supposed to be done. Therefore, it was investigated whether or not iron absorption and absorption by vinegar were promoted in iron-deficient rats.

【0025】プルーン果汁を原料とするプルーン酢を、
酢酸換算の酸度として、1.25w/v%となるよう
に、蒸留水で酸度調整し、本願発明となる鉄吸収促進剤
1aを得た。
Prune vinegar made from prune juice
The acidity was adjusted with distilled water so that the acidity in terms of acetic acid was 1.25 w / v% to obtain an iron absorption promoter 1a according to the present invention.

【0026】これとは別に、6週齢の雄Wistarラ
ット10匹を、低鉄飼料を与えて6日間飼育し、その後
一晩絶食させた。
Separately, 10 6-week-old male Wistar rats were fed a low iron diet for 6 days and then fasted overnight.

【0027】一晩絶食させたラットを5匹ずつの2つの
群に分けた。第1群には、鉄吸収促進剤1aと、ラット
の体重1kg当たり、鉄含量として2.25mgのサン
アクティブ鉄(太陽化学株式会社製)を混合した溶液を
経口投与した。第2群には、蒸留水と、ラットの体重1
kg当たり、鉄含量として2.25mgのサンアクティ
ブ鉄(太陽化学株式会社製)を混合した溶液を経口投与
し、コントロールとした。
Rats fasted overnight were divided into two groups of 5 animals each. The first group was orally administered with a solution obtained by mixing the iron absorption enhancer 1a and 2.25 mg of Sunactive Iron (manufactured by Taiyo Kagaku Co., Ltd.) as iron content per 1 kg of rat body weight. The second group contained distilled water and a rat body weight of 1
A solution in which 2.25 mg of iron content per kg of Sunactive Iron (manufactured by Taiyo Kagaku Co., Ltd.) was orally administered and used as a control.

【0028】経口投与してから1.5時間後に、それぞ
れのラットから血液を採取し、遠心分離して得られた血
清中の鉄濃度を測定した。
1.5 hours after oral administration, blood was collected from each rat and centrifuged to measure the iron concentration in the obtained serum.

【0029】その結果、蒸留水を投与した第2群の血清
中の鉄濃度平均を1とすると、鉄吸収促進剤1aを投与
した第1群の血清中の鉄濃度平均は、1.25となっ
た。これより、鉄欠乏状態において、本願発明の鉄吸収
促進剤は優れた鉄吸収促進効果を発揮することが証明さ
れた。
As a result, when the average iron concentration in the serum of the second group to which distilled water was administered was 1, the average iron concentration in the serum of the first group to which the iron absorption promoter 1a was administered was 1.25. became. From this, it was proved that the iron absorption promoter of the present invention exerts an excellent iron absorption promoting effect in the iron deficiency state.

【0030】(実施例2) 鉄吸収促進剤の鉄吸収特性 プルーン果汁を原料とするプルーン酢を、酢酸換算の酸
度として、それぞれ、0.3w/v%、0.6w/v
%、1.25w/v%、2.5w/v%となるように、
蒸留水で酸度調整し、本願発明となる鉄吸収促進剤2
a、2b、2c及び2dを得た。
Example 2 Iron Absorption Properties of Iron Absorption Promoters Prune vinegar made from prune juice was used as acetic acid equivalent acidity of 0.3 w / v% and 0.6 w / v, respectively.
%, 1.25 w / v%, 2.5 w / v%,
Iron absorption promoter 2 which is the present invention by adjusting the acidity with distilled water
a, 2b, 2c and 2d were obtained.

【0031】これとは別に、1週間予備飼育した6週齢
の雄Wistarラット30匹を一晩絶食させた。
Separately, 30 6-week-old male Wistar rats preliminarily bred for 1 week were fasted overnight.

【0032】一晩絶食させたラットを6匹ずつの5つの
群に分けた。第1群には、鉄吸収促進剤2aとサンアク
ティブ鉄を混合した溶液を経口投与した。第2群には、
鉄吸収促進剤2bとサンアクティブ鉄を混合した溶液を
経口投与した。第3群には、鉄吸収促進剤2cとサンア
クティブ鉄を混合した溶液を経口投与した。第4群に
は、鉄吸収促進剤2dとサンアクティブ鉄を混合した溶
液を経口投与した。第5群には、蒸留水とサンアクティ
ブ鉄を混合した溶液を経口投与し、コントロールとし
た。ここで、サンアクティブ鉄は、いずれも太陽化学株
式会社製を使用し、その混合量は、ラットの体重1kg
当たり、鉄含量として2.25mgとなるようにした。
Rats fasted overnight were divided into 5 groups of 6 animals each. The first group was orally administered with a solution in which the iron absorption promoter 2a and Sunactive Iron were mixed. In the second group,
A solution in which the iron absorption promoter 2b and Sunactive Iron were mixed was orally administered. The third group was orally administered with a solution of the iron absorption enhancer 2c and Sunactive iron. A solution obtained by mixing the iron absorption enhancer 2d and Sunactive Iron was orally administered to the fourth group. A solution obtained by mixing distilled water and Sunactive Iron was orally administered to the fifth group, which served as a control. Here, the sun active iron is manufactured by Taiyo Kagaku Co., Ltd., and the mixing amount is 1 kg of rat body weight.
Therefore, the iron content was adjusted to 2.25 mg.

【0033】経口投与してから1.5時間後に、ラット
から血液を採取し、遠心分離して得られた血清中の鉄濃
度を測定した。
1.5 hours after oral administration, blood was collected from the rat and centrifuged to measure the iron concentration in the obtained serum.

【0034】その結果、蒸留水を投与した第5群の血清
中の鉄濃度平均を1とすると、鉄吸収促進剤2a〜2c
を投与した第1群〜第4群の血清中の鉄濃度平均は、そ
れぞれ1.02、1.07、1.13、0.87となっ
た。これより、本願発明の鉄吸収促進剤は、0.3w/
v%、0.6w/v%、1.25w/v%について高い
鉄吸収促進効果を有することが確認された。
As a result, assuming that the average iron concentration in the serum of the fifth group administered with distilled water is 1, the iron absorption promoters 2a to 2c
The average iron concentration in the serum of the first to fourth groups administered with was 1.02, 1.07, 1.13, and 0.87, respectively. From this, the iron absorption promoter of the present invention is 0.3 w /
It was confirmed that v%, 0.6 w / v%, and 1.25 w / v% had a high iron absorption promoting effect.

【0035】[0035]

【発明の効果】本願発明の鉄吸収促進剤は、腸管におけ
る鉄の吸収を促進せしめるため、鉄欠乏に起因する種々
の疾病の治療及び予防、更には、若年女性に見られる潜
在性鉄欠乏の改善等に効果が発揮される。
The iron absorption enhancer of the present invention accelerates the absorption of iron in the intestinal tract, and therefore, it can treat and prevent various diseases caused by iron deficiency, and can further reduce the latent iron deficiency observed in young women. Effective for improvement.

【0036】本願発明の鉄吸収促進剤は、安全性が高
く、継続的な摂取も可能であり、かつ大量に供給するこ
ともでき、食品への添加も容易であるため、人間の健康
増進などに貢献するところが大である。
The iron absorption enhancer of the present invention is highly safe, can be continuously ingested, can be supplied in a large amount, and can be easily added to foods. It is a big contribution to.

【0037】本願発明の鉄吸収促進剤は、鉄の利用が不
十分であるために起こる症状、例えば、貧血、頭痛、耳
鳴り、息切れ、眩暈、運動障害、倦怠感等や献血後、手
術後、産後の鉄欠乏状態への適用が期待される。
The iron absorption promoter of the present invention is a symptom caused by insufficient utilization of iron, such as anemia, headache, tinnitus, shortness of breath, dizziness, dyskinesia, malaise and the like, after blood donation, after surgery, Application to postpartum iron deficiency is expected.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 末田 美濃 奈良県大和郡山市西町100番地 タマノイ 酢株式会社中央研究所内 (72)発明者 氏家 聡 奈良県大和郡山市西町100番地 タマノイ 酢株式会社中央研究所内 Fターム(参考) 4C206 AA01 AA02 DA02 MA01 MA72 NA14 ZA55 ZC75 ZC80    ─────────────────────────────────────────────────── ─── Continued front page    (72) Inventor Mino Sueda             Tamanoi 100 Nishimachi, Yamatokoriyama City, Nara Prefecture             Vinegar Co., Ltd. Central Research Institute (72) Inventor Satoshi Ujiie             Tamanoi 100 Nishimachi, Yamatokoriyama City, Nara Prefecture             Vinegar Co., Ltd. Central Research Institute F-term (reference) 4C206 AA01 AA02 DA02 MA01 MA72                       NA14 ZA55 ZC75 ZC80

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 食酢を含有してなることを特徴とする鉄
吸収促進剤。
1. An iron absorption enhancer comprising vinegar.
【請求項2】 食酢は、果実酢、黒酢、米酢、アルコー
ル酢、穀物酢のうちいずれか一種以上からなることを特
徴とする請求項1記載の鉄吸収促進剤。
2. The iron absorption enhancer according to claim 1, wherein the vinegar comprises at least one of fruit vinegar, black vinegar, rice vinegar, alcohol vinegar and grain vinegar.
【請求項3】 食酢を、酢酸換算の酸度として、0.3
w/v%以上1.3w/v%以下含有してなることを特
徴とする請求項1又は2記載の鉄吸収促進剤。
3. Vinegar has an acidity of acetic acid equivalent of 0.3.
The iron absorption promoter according to claim 1 or 2, wherein the iron absorption promoter is contained in a content of w / v% or more and 1.3 w / v% or less.
【請求項4】 プルーン酢を、酢酸換算の酸度として、
0.3w/v%以上1.3w/v%以下含有してなるこ
とを特徴とする鉄吸収促進剤。
4. Pruned vinegar having an acidity of acetic acid equivalent,
An iron absorption promoter containing 0.3 w / v% or more and 1.3 w / v% or less.
JP2001343851A 2001-11-08 2001-11-08 Iron absorption promoter Pending JP2003146873A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001343851A JP2003146873A (en) 2001-11-08 2001-11-08 Iron absorption promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001343851A JP2003146873A (en) 2001-11-08 2001-11-08 Iron absorption promoter

Publications (1)

Publication Number Publication Date
JP2003146873A true JP2003146873A (en) 2003-05-21

Family

ID=19157465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001343851A Pending JP2003146873A (en) 2001-11-08 2001-11-08 Iron absorption promoter

Country Status (1)

Country Link
JP (1) JP2003146873A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005198645A (en) * 2003-05-22 2005-07-28 Lion Corp Fermented liquid of tomato, hypotensive agent, method for producing the same, and eating and drinking composition
EP2420243A1 (en) 2010-08-18 2012-02-22 Inovativo Biomedicinas Tehnologiju Instituts, SIA Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005198645A (en) * 2003-05-22 2005-07-28 Lion Corp Fermented liquid of tomato, hypotensive agent, method for producing the same, and eating and drinking composition
EP2420243A1 (en) 2010-08-18 2012-02-22 Inovativo Biomedicinas Tehnologiju Instituts, SIA Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming

Similar Documents

Publication Publication Date Title
RU2356247C2 (en) Combinations and compositions containing fatty acids and amino acids, their application for prevention and delay of progressing or treatment of diabetes and diabetes associated diseases and conditions, method of weight reduction in mammal, kit
US20170035725A1 (en) Muscle atrophy inhibitor
CN1275534C (en) Corn peptide beverage and its processing method
US10021900B2 (en) Carbohydrate composition and food and beverage producing gradual rise in blood glucose levels
US20090258111A1 (en) Highly bioavailable oral administration composition of cryptoxanthin
JP2009173634A (en) LIPID ABSORPTION INHIBITOR CONTAINING POLY-gamma-GLUTAMIC ACID
JPH0920661A (en) Learning ability-improving composition
WO2012121140A1 (en) Growth hormone secretion promoter
JP2006193502A (en) Adiponectin regulating agent and food, drink, food additive and medicine containing the same
EP2030629B1 (en) Alpha-s-casein as lipid-metabolism-improving agent
JP2008088151A (en) Application of polymer material included in soy sauce
WO2012115026A1 (en) Tomatoside a-containing composition
JP4395658B2 (en) Composition for inhibiting cholesterol re-elevation and method of use thereof
JP4673071B2 (en) Iron-adsorptive polymer substance, iron-containing polymer substance, and production method thereof
US20060210606A1 (en) Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood
JP7090849B2 (en) Liver function improving composition and liver function improving food composition
KR20190140737A (en) Vinegar compositions comprising detox-diet material and manufacturing method thereof
CN114680339A (en) Nutritional supplement for improving muscle attenuation and delaying senescence and application thereof
JP2003146873A (en) Iron absorption promoter
JPH0797323A (en) Iron absorption promoter
KR20080103528A (en) Accelerating agent of calcium absorption
CN114145457A (en) Hypoglycemic composition
JP4022350B2 (en) Composition having an inhibitory effect on cholesterol elevation and an inhibitory effect on HDL-cholesterol lowering
JP2013177330A (en) Anti-inflammatory agent including lees of sweet potato distilled spirit or its treated material
EP3908300A1 (en) Production and use of yeast extract as a medical adjuvant

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060725

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070109